CN112279905A - Preparation process of conus anti-wrinkle agent - Google Patents

Preparation process of conus anti-wrinkle agent Download PDF

Info

Publication number
CN112279905A
CN112279905A CN202011079899.2A CN202011079899A CN112279905A CN 112279905 A CN112279905 A CN 112279905A CN 202011079899 A CN202011079899 A CN 202011079899A CN 112279905 A CN112279905 A CN 112279905A
Authority
CN
China
Prior art keywords
conus
conotoxin
wrinkle
disulfide bonds
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011079899.2A
Other languages
Chinese (zh)
Inventor
沈永刚
肖攀
谢振亮
付坤
沈永良
程益明
胡桂香
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Gotop Biotechnology Co ltd
Original Assignee
Hangzhou Gotop Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Gotop Biotechnology Co ltd filed Critical Hangzhou Gotop Biotechnology Co ltd
Priority to CN202011079899.2A priority Critical patent/CN112279905A/en
Publication of CN112279905A publication Critical patent/CN112279905A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a preparation process of conus anti-wrinkle essence, which comprises the following steps: 1) selecting Sieber Amide Resin with substitution degree of 0.3-0.6mmol/g, and removing Fmoc after swelling; 2) sequentially coupling the amino acid sequence of the conotoxin as shown in SEQ ID NO.1 to the last amino acid H-Pyr-OH; 3) cracking conus anti-wrinkle linear peptide from Sieber Amide Resin, and cyclizing the first pair of disulfide bonds with 25% mercaptoethanol/DMF solution; 4) cracking and removing all side chain protecting groups to obtain conotoxin precursor peptide containing a pair of disulfide bonds, and naturally oxidizing after dissolution to obtain crude conotoxin peptide forming three pairs of disulfide bonds; 5) separating, purifying, transferring salt and freeze-drying to obtain the conus anti-wrinkle essence product. The technology adopts Fmoc solid phase synthesis strategy, utilizes various condensing agent systems, dipeptide raw materials, positioning oxidation and natural oxidation to obtain the conotoxin, has the characteristics of high reaction operation efficiency, low cost, high yield and the like, and is suitable for large-scale production.

Description

Preparation process of conus anti-wrinkle agent
Technical Field
The invention relates to a preparation process for polypeptide synthesis, in particular to a preparation process for conotoxin.
Background
The conus anti-wrinkle agent is a highly folded peptide, is commonly used in the field of cosmetics, can play an anti-wrinkle effect, and has high stability and strong penetrating power due to the unique spatial structure. The conotoxin is composed of 22 amino acids, and the specific sequence is as follows: pyr1-Gly2-Cys3-Cys4-Asn5-Gly6-Pro7-Lys8-Gly9-Cys10-Ser11-Ser12-Lys13-Trp14-Cys15-Arg16-Asp17-His18-Ala19-Arg20-Cys21-Cys22-NH2(Disulfide bond: Cys3-Cys15, Cys4-Cys21, Cys10-Cys22), Casno.:936616-33-0, molecular formula: C92H139N35O28S, molecular weight: 2375.76.
because conus anti-wrinkle essence has three pairs of disulfide bonds, according to the traditional solid-phase synthesis and oxidation thinking, the positioned cyclization is realized by utilizing the differentiation of different side chain protecting groups of three pairs of Cys, and the defects of complicated steps, more side reactions, low yield, low operability, incapability of large-scale production and the like are brought. And three pairs of disulfide bonds are formed by natural oxidation, several forms of isomers can appear, the purification difficulty can be improved, and the final yield of the product is greatly reduced.
Therefore, on the premise, the synthesis scheme and the oxidation process of the conus anti-wrinkle element are improved and optimized, so that the aims of increasing the yield of the conus anti-wrinkle element again and realizing large-scale production are fulfilled.
Disclosure of Invention
The invention provides a preparation process of conotoxin, which aims to shorten the synthesis time, improve the purity of conotoxin straight-chain peptide and well solve the problems of more side reactions, low yield and poor operability caused by cyclization reaction of three pairs of disulfide bonds.
In order to achieve the purpose, the invention provides the following technical scheme:
a preparation process of conus anti-wrinkle essence comprises the following steps:
1) selecting Sieber Amide Resin with substitution degree of 0.3-0.6mmol/g, and removing Fmoc after swelling;
2) coupling conus anti-wrinkle straight-chain peptide resin: sequentially coupling the C end to the N end of the amino acid sequence of the conus anti-wrinkle element shown as SEQ ID NO.1 to the last amino acid H-Pyr-OH of the N end to obtain the conus anti-wrinkle element straight-chain peptide resin; wherein, the amino acids used at the 3 rd, 4 th, 15 th and 21 st positions of the N terminal are Fmoc-Cys (Trt) -OH, the amino acids used at the 10 th and 22 th positions are Fmoc-Cys (StBu) -OH, the reaction raw materials used at the 6 th and 7 th positions are Fmoc-Gly-Pro-OH, and the reaction raw materials used at the 11 th and 12 th positions are Fmoc-Ser (tBu) -OH; the side chain protecting groups of Asn, Lys, Trp, Arg, Asp and His are respectively Trt, Boc, Pbf, OtBu and Trt;
3) reacting TFA/DCM solution with conotoxin straight chain peptide resin, filtering to obtain conotoxin straight chain peptide with side chain protecting group, and cyclizing a first pair of disulfide bonds by mercaptoethanol/DMF to obtain a precursor peptide of conotoxin anti-wrinkle peptide with side chain protecting group containing a pair of disulfide bonds;
4) after the first cyclization is completed, removing all side chain protecting groups on the precursor peptide of the conotoxin anti-wrinkle peptide with side chain protecting groups containing a pair of disulfide bonds by using a lysis solution to obtain the conotoxin anti-wrinkle precursor peptide containing a pair of disulfide bonds, adjusting the PH of the solution to 8-9 by using dilute ammonia water after dissolution, and performing cyclization of a second pair of disulfide bonds and a third pair of disulfide bonds under natural conditions to obtain a crude conotoxin peptide;
5) and (4) performing semi-preparative chromatographic separation and freeze-drying to obtain the conotoxin product.
Preferably, the coupling system is formed by combining any one of HOBT, HOAT and Cl-HOBT with DIC, or by combining any one of HBTU, HATU, PyBOP or PyAOP with DIEA, or by combining any one of HBTU, HATU, PyBOP or PyAOP with any one of HOBT, HOAT and Cl-HOBT with DIEA.
Preferably, in the step 1), the substitution degree of the Sieber Amide Resin is 0.34-0.45 mmol/g.
Preferably, in the selection of side chain protecting groups of Cys, the 10 th and 22 th Cys side chain protecting groups can be selected to be StBu, and the rest Cys side chain protecting groups are Trt; or the protecting groups of the Cys side chains at the 4 th position and the 21 st position are StBu, and the protecting groups of the other Cys side chains are Trt; or the Cys side chain protecting groups at the 3 rd and 15 th positions are StBu, and the rest Cys side chain protecting groups are Trt.
Preferably, in step 2), when Fmoc-Gly-Pro-OH is used as a reaction raw material at the 6 th and 7 th positions and Fmoc-Ser (tBu) -OH is used as a reaction raw material at the 11 th and 12 th positions, the reaction raw material is 2 times the mole number of the Sieber Amide Resin.
Preferably, in step 3), the ratio of TFA to DCM in the TFA/DCM solution is 2% -8% by volume.
Preferably, in step 3), the ratio of TFA to DCM in the TFA/DCM solution is 3% by volume.
Preferably, in step 3), the volume ratio of mercaptoethanol to DMF in the mercaptoethanol/DMF solution is 15% -35%, and the oxidizing agent and the solvent used for the cyclization of the first pair of disulfide bonds is H2O2DCM, in which H2O2The volume ratio of the active component to DCM is 0.5% -1.5%.
Preferably, in the step 4), the volume ratio of each component of the lysate for cleaving the conus anti-wrinkle side chain protecting group precursor peptide containing a pair of disulfide bonds is TFA: ethanedithiol: phenol: triisopropylsilane: water ═ 85-90): (5-8): (3-4): (2-3): (1-3).
Preferably, in the step 4), the second and third pairs of disulfide bonds are cyclized by using an air oxidation method, and the reaction time is 48-72 h.
Compared with the prior art, the invention has the beneficial effects that:
the process of the invention uses Fmoc solid phase method, selectively oxidizes the mixture to form a pair of disulfide bonds, then forms the remaining two pairs of disulfide bonds by natural oxidation, selects dipeptide fragments to carry out coupling, has the characteristics of high yield, strong operability and the like, is suitable for large-scale production, has considerable economic and practical values, and has wide application prospect in the field of cosmetics.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
a preparation process of conus anti-wrinkle agent with amino acid sequence shown as SEQ ID NO.1
The method comprises the following specific steps:
1) weighing 100g of Sieber Amide Resin with the substitution degree of 0.40mmol/g into a reaction column, adding a proper amount of DCM for swelling for 15min, washing for 3 times by DMF after pumping, pumping for drying, adding a proper amount of decapping solution for reacting for 5min, pumping for drying the decapping solution, washing for one time by DMF, then adding a proper amount of decapping solution for reacting for 10min, pumping for drying the decapping solution, washing for 6 times by DMF, and pumping for drying, wherein the decapping solution is prepared by DBLK and DMF according to the volume ratio of 1: 4 is configured.
2) Weighing 34.52g of Fmoc-Cys (StBu) -OH and 25.69g of TBTU, completely dissolving in a proper amount of DMF, slowly adding 26.44ml of DIEA under an ice bath condition, slowly stirring, slowly adding a uniformly stirred mixed solution of Fmoc-Cys (StBu) -OH and TBTU/DIEA into a reaction column, introducing nitrogen at room temperature for reaction for 1H, then carrying out Kaiser detection, draining after the coupling reaction is finished, washing with DMF for 3 times, and sequentially coupling according to a conotoxin anti-wrinkle sequence until the last amino acid H-Pyr-OH is coupled; the resin was weighed 324.55g by washing 3 times with DMF, DCM and MeOH in sequence and draining.
Wherein, the Cys side chain protecting groups at the 10 th and 22 th positions are StBu, and the rest Cys side chain protecting groups are Trt; the amino acid used at the 6 th and 7 th positions was Fmoc-Gly-Pro-OH, the weight of the Fmoc-Gly-Pro-OH was 31.55g, the reaction material used at the 11 th and 12 th positions was Fmoc-Ser (tBu) -OH, and the weight was 42.14g, wherein the coupling system consisted of 41.63g of PyBop and 26.44ml of DIEA.
3) And (3) filling the conotoxin straight-chain peptide resin after coupling is finished into a reactor, and configuring a TFA/DCM volume ratio of 5: 3500ml of 95 lysate, slow stirring, reaction for 2h, suction filtration to obtain filtrate, adding DIEA to adjust the pH value to alkalinity, and then carrying out rotary evaporation and concentration on the filtrate to obtain 215.42g of taro snail anti-wrinkle linear peptide oily liquid with side chain protecting groups.
4) Preparing 400ml of mercaptoethanol/DMF solution with the volume ratio of 25% for cyclization of a first pair of disulfide bonds, judging the reaction degree through a high performance liquid chromatograph and a mass spectrometer after the reaction is carried out for 30min, adding water to separate out the conus anti-wrinkle tape side chain protecting group precursor peptide containing a pair of disulfide bonds after the reaction is finished, filtering to obtain a conus anti-wrinkle tape side chain protecting group precursor peptide solid matter containing a pair of disulfide bonds, and drying and weighing 191.89 g.
5) TFA in volume ratio: ethanedithiol: phenol: triisopropylsilane: water 87: 5: 3: 3: 2, preparing 1000ml of lysate, slowly adding the lysate into the conus anti-wrinkle element precursor peptide with side chain protecting groups containing a pair of disulfide bonds under the ice bath condition, stirring while adding, removing the ice bath after 30min, continuing to react for 1.5h, adding 8000ml of glacial ethyl ether to precipitate the conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, filtering the separated crude polypeptide, washing for 3 times by using a proper amount of glacial ethyl ether to obtain the solid conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, drying, and weighing 107.32 g.
6) Dissolving the conus anti-wrinkle peptide precursor containing a pair of disulfide bonds into 3000ml of pure water, adjusting the pH of a peptide solution to 8 by using dilute ammonia water, slowly stirring, carrying out cyclization of a second pair of disulfide bonds and a third pair of disulfide bonds under natural conditions, tracking and judging by using a high performance liquid chromatograph and a mass spectrometer every 3 hours, detecting that the reaction is finished after 63 hours, obtaining the crude conus anti-wrinkle peptide product, and adding dilute acetic acid to adjust the pH value of the aqueous solution of the crude conus anti-wrinkle peptide product to be 5-6.
7) Filtering the crude product water solution of the conus anti-wrinkle essence by using a 0.45 mu m filter membrane, and purifying the improved crude peptide by using a high performance liquid chromatography instrument: the method comprises the steps of passing through a DAC-HB50 dynamic axial compression column, enabling a mobile phase A to be a trifluoroacetic acid aqueous solution with the mass percentage concentration of 0.05%, enabling a mobile phase B to be a trifluoroacetic acid acetonitrile solution with the mass percentage concentration of 0.05%, carrying out gradient elution separation and purification, detecting a sample by an ultraviolet detector, collecting a peptide solution of a target peak in a segmented mode, carrying out high-efficiency liquid phase purification to obtain 850ml of conus anti-wrinkle element trifluoroacetic acid liquid with the purity of more than 98%, carrying out rotary evaporation concentration to obtain 300ml of liquid, balancing a chromatographic column with deionized water, loading the sample with the sample amount of 300ml of conus anti-wrinkle element trifluoroacetic acid liquid with the purity of more than 98%, eluting for 50min under a 2% acetic acid aqueous solution system, carrying out rotary concentration on the collected target product to 350ml, carrying out pre-freeze-drying and freeze-drying treatment, and finally obtaining the conus anti-wrinkle.
Example two:
a preparation process of conus anti-wrinkle agent with amino acid sequence shown as SEQ ID NO.1
The method comprises the following specific steps:
1) weighing 100g of Sieber Amide Resin with the substitution degree of 0.40mmol/g into a reaction column, adding a proper amount of DCM for swelling for 15min, washing for 3 times by DMF after pumping, pumping for drying, adding a proper amount of decapping solution for reacting for 5min, pumping for drying the decapping solution, washing for one time by DMF, then adding a proper amount of decapping solution for reacting for 10min, pumping for drying the decapping solution, washing for 6 times by DMF, and pumping for drying, wherein the decapping solution is prepared by DBLK and DMF according to the volume ratio of 1: 4 is configured.
2) Weighing 48.86g of Fmoc-Cys (Trt) -OH and 25.69g of TBTU, completely dissolving in a proper amount of DMF, slowly adding 26.44ml of DIEA under an ice bath condition, slowly stirring, slowly adding the uniformly stirred mixed solution of Fmoc-Cys (Trt) -OH and TBTU/DIEA into a reaction column, introducing nitrogen at room temperature for reaction for 1H, carrying out Kaiser detection, draining after the coupling reaction is finished, washing with DMF for 3 times in an anti-wrinkle manner, and sequentially coupling according to the sequence of conotoxin until the last amino acid H-Pyr-OH is coupled. The resin was weighed 335.27g by washing 3 times with DMF, DCM and MeOH in sequence and draining.
Wherein, the protecting groups of the Cys side chains at the 4 th position and the 21 st position are StBu, and the protecting groups of the other Cys side chains are Trt; 31.55g of Fmoc-Gly-Pro-OH was used as a reaction material at the 6 th and 7 th positions, and 42.14g of Fmoc-Ser (tBu) -OH was used as a reaction material at the 11 th and 12 th positions, wherein the coupling system consisted of 41.63g of PyBop and 26.44ml of DIEA.
3) And (3) filling the conotoxin straight-chain peptide resin after coupling is finished into a reactor, and configuring a TFA/DCM volume ratio of 5: 3500ml of 95 lysate, slow stirring, reaction for 2h, suction filtration to obtain filtrate, adding DIEA to adjust the pH value to alkalinity, and then carrying out rotary evaporation and concentration on the filtrate to obtain 209.39g of taro snail anti-wrinkle linear peptide oily liquid with side chain protecting groups.
4) Preparing 400ml of mercaptoethanol/DMF solution with the volume ratio of 25% for cyclization of a first pair of disulfide bonds, judging the reaction degree through a high performance liquid chromatograph and a mass spectrometer after the reaction is carried out for 30min, adding water to separate out the conus anti-wrinkle tape side chain protecting group precursor peptide containing a pair of disulfide bonds after the reaction is finished, filtering to obtain a conus anti-wrinkle tape side chain protecting group precursor peptide solid matter containing a pair of disulfide bonds, and drying and weighing 198.22 g.
5) TFA in volume ratio: ethanedithiol: phenol: triisopropylsilane: water 87: 5: 3: 3: 2, preparing 1000ml of lysate, slowly adding the lysate into the conus anti-wrinkle element precursor peptide with side chain protecting groups containing a pair of disulfide bonds under the ice bath condition, stirring while adding, removing the ice bath after 30min, continuing to react for 1.5h, adding 8000ml of glacial ethyl ether to precipitate the conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, filtering the separated crude polypeptide, washing for 3 times by using a proper amount of glacial ethyl ether to obtain the solid conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, drying, and weighing 113.28 g.
6) Dissolving the conus anti-wrinkle peptide precursor containing a pair of disulfide bonds into 3000ml of pure water, adjusting the pH of a peptide solution to 8 by using dilute ammonia water, slowly stirring, carrying out cyclization of a second pair of disulfide bonds and a third pair of disulfide bonds under natural conditions, tracking and judging by using a high performance liquid chromatograph and a mass spectrometer every 3 hours, detecting that the reaction is finished after 66 hours, obtaining the crude conus anti-wrinkle peptide product, and adding dilute acetic acid to adjust the pH value of the aqueous solution of the crude conus anti-wrinkle peptide product to be 5-6.
7) Filtering the aqueous solution of crude conotoxin peptides with a 0.45-micrometer filter membrane, and purifying the improved crude peptides with a high performance liquid chromatography: and (2) performing gradient elution, separation and purification by passing through a DAC-HB50 dynamic axial compression column, wherein a mobile phase A is a trifluoroacetic acid aqueous solution with the mass percentage concentration of 0.05%, and a mobile phase B is a trifluoroacetic acid acetonitrile solution with the mass percentage concentration of 0.05%, detecting a sample by adopting an ultraviolet detector, and collecting a peptide solution of a target peak in a segmented manner. 650ml of conotoxin trifluoroacetic acid liquid with the purity of more than 98 percent is obtained by high performance liquid purification, and 200ml of liquid is obtained by rotary evaporation and concentration. The chromatographic column is balanced by deionized water and then is loaded, 200ml of cone snail anti-wrinkle element trifluoroacetic acid liquid with the purity of more than 98 percent is eluted for 50min in a 2 percent acetic acid aqueous solution system, the collected target product is rotationally concentrated to 280ml, pre-freeze drying and freeze drying are carried out, and finally the weight of the cone snail anti-wrinkle element is 25.72g, and the yield is 27.06 percent.
Example three:
a preparation process of conus anti-wrinkle agent with amino acid sequence shown as SEQ ID NO.1
The method comprises the following specific steps:
1) weighing Sieber Amide Resin (100g) with the substitution degree of 0.40mmol/g into a reaction column, adding a proper amount of DCM for swelling for 15min, washing with DMF for 3 times after draining, adding a proper amount of decapping solution for reaction for 5min, draining the decapping solution, washing with DMF once, then adding a proper amount of decapping solution for reaction for 10min, draining the decapping solution, washing with DMF for 6 times, and draining, wherein the decapping solution is prepared by DBLK and DMF according to the volume ratio of 1: 4 is configured.
2) Weighing 48.86g of Fmoc-Cys (Trt) -OH and 25.69g of TBTU, completely dissolving in a proper amount of DMF, slowly adding 26.44ml of DIEA under an ice bath condition, slowly stirring, slowly adding the uniformly stirred mixed solution of Fmoc-Cys (Trt) -OH and TBTU/DIEA into a reaction column, introducing nitrogen at room temperature for reaction for 1H, carrying out Kaiser detection, draining after the coupling reaction is finished, washing with DMF for 3 times in an anti-wrinkle manner, and sequentially coupling according to the sequence of conotoxin until the last amino acid H-Pyr-OH is coupled. The resin was weighed 322.98g by washing 3 times with DMF, DCM and MeOH in sequence and draining.
Wherein, the Cys side chain protecting groups at the 3 rd and 15 th positions are StBu, and the rest Cys side chain protecting groups are Trt; 31.55g of Fmoc-Gly-Pro-OH is used as a reaction raw material at the 6 th position and the 7 th position, and 42.14g of Fmoc-Ser (tBu) -OH is used as a reaction raw material at the 11 th position and the 12 th position, wherein a coupling system consists of 41.63g of PyBop and 26.44ml of DIEA.
3) And (3) filling the conotoxin straight-chain peptide resin after coupling is finished into a reactor, and configuring a TFA/DCM volume ratio of 5: 3500ml of 95 lysate, slow stirring, reaction for 2h, suction filtration to obtain filtrate, adding DIEA to adjust the pH value to alkalinity, and then carrying out rotary evaporation and concentration on the filtrate to obtain 192.86g of taro snail anti-wrinkle linear peptide oily liquid with side chain protecting groups.
4) Preparing 400ml of mercaptoethanol/DMF solution with the volume ratio of 25% for cyclization of a first pair of disulfide bonds, judging the reaction degree through a high performance liquid chromatograph and a mass spectrometer after the reaction is carried out for 30min, adding water to separate out the conus anti-wrinkle tape side chain protecting group precursor peptide containing a pair of disulfide bonds after the reaction is finished, filtering to obtain a conus anti-wrinkle tape side chain protecting group precursor peptide solid matter containing a pair of disulfide bonds, and drying and weighing 179.92 g.
5) TFA in volume ratio: ethanedithiol: phenol: triisopropylsilane: water 87: 5: 3: 3: 2, preparing 1000ml of lysate, slowly adding the lysate into the conus anti-wrinkle element precursor peptide with side chain protecting groups containing a pair of disulfide bonds under the ice bath condition, stirring while adding, removing the ice bath after 30min, continuing to react for 1.5h, adding 8000ml of glacial ethyl ether to precipitate the conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, filtering the separated crude polypeptide, washing for 3 times by using a proper amount of glacial ethyl ether to obtain the solid conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, drying, and weighing 107.68 g.
6) Dissolving the conus anti-wrinkle peptide precursor containing a pair of disulfide bonds into 3000ml of pure water, adjusting the pH of a peptide solution to 8 by using dilute ammonia water, slowly stirring, carrying out cyclization of a second pair of disulfide bonds and a third pair of disulfide bonds under natural conditions, tracking and judging by using a high performance liquid chromatograph and a mass spectrometer every 3h, detecting that the reaction is finished after 69h, obtaining the conus anti-wrinkle peptide crude product, and adding dilute acetic acid to adjust the pH value of the conus anti-wrinkle peptide crude product aqueous solution to 5-6.
7) Filtering the crude product water solution of the conus anti-wrinkle essence by using a 0.45 mu m filter membrane, and purifying the improved crude peptide by using a high performance liquid chromatography instrument: and (2) performing gradient elution, separation and purification by passing through a DAC-HB50 dynamic axial compression column, wherein a mobile phase A is a trifluoroacetic acid aqueous solution with the mass percentage concentration of 0.05%, and a mobile phase B is a trifluoroacetic acid acetonitrile solution with the mass percentage concentration of 0.05%, detecting a sample by adopting an ultraviolet detector, and collecting a peptide solution of a target peak in a segmented manner. 700ml of conus anti-wrinkle element trifluoroacetic acid liquid with the purity of more than 98 percent is obtained by high performance liquid purification, and 280ml of liquid is obtained after rotary evaporation and concentration. The chromatographic column is balanced by deionized water and then is loaded, the loading amount is 280ml of cone snail anti-wrinkle element trifluoroacetic acid liquid with the purity of more than 98 percent, elution is carried out for 50min under a 2 percent acetic acid aqueous solution system, the collected target product is rotationally concentrated to 330ml, pre-freeze-drying and freeze-drying treatment are carried out, and finally the weight of the cone snail anti-wrinkle element is 25.55g, and the yield is 26.89 percent.
In conclusion, the invention synthesizes the conus anti-wrinkle essence by using an Fmoc solid phase method, selects dipeptide fragments as raw materials for coupling, and then positions and oxidizes a pair of disulfide bonds first and then completes the formation of the remaining two pairs of disulfide bonds by natural oxidation, thereby effectively avoiding the formation of isomers, promoting the reaction to be carried out towards a specified line, improving the production efficiency and the product yield, having strong operability, having considerable economic and practical values and being suitable for large-scale production.
The comparison table of the names of the raw materials in the present invention and the names of the raw materials is shown in table 1.
TABLE 1 comparison table of raw material name abbreviations and raw material names
Figure BDA0002718387330000081
Figure BDA0002718387330000091
The sequence structures of corresponding substances in different stages in the process of preparing the conus anti-wrinkle agent are as follows:
conus anti-wrinkle straight-chain peptide:
Figure BDA0002718387330000101
conus anti-wrinkle peptide precursor with side chain protecting group containing a pair of disulfide bonds:
Figure BDA0002718387330000102
conus anti-wrinkle precursor peptide containing a pair of disulfide bonds:
Figure BDA0002718387330000103
conotoxin anti-wrinkle agent:
Figure BDA0002718387330000104
the foregoing is merely exemplary and illustrative of the present invention and various modifications, additions and substitutions may be made by those skilled in the art to the specific embodiments described without departing from the scope of the invention as defined in the following claims.

Claims (10)

1. A preparation process of conotoxin is characterized by comprising the following steps:
1) selecting Sieber Amide Resin with substitution degree of 0.3-0.6mmol/g, and removing Fmoc after swelling;
2) coupling conus anti-wrinkle straight-chain peptide resin: sequentially coupling the C end to the N end of the amino acid sequence of the conus anti-wrinkle element shown as SEQ ID NO.1 to the last amino acid H-Pyr-OH of the N end to obtain the conus anti-wrinkle element straight-chain peptide resin; wherein, the amino acids used at the 3 rd, 4 th, 15 th and 21 st positions of the N terminal are Fmoc-Cys (Trt) -OH, the amino acids used at the 10 th and 22 th positions are Fmoc-Cys (StBu) -OH, the reaction raw materials used at the 6 th and 7 th positions are Fmoc-Gly-Pro-OH, and the reaction raw materials used at the 11 th and 12 th positions are Fmoc-Ser (tBu) -OH; the side chain protecting groups of Asn, Lys, Trp, Arg, Asp and His are respectively Trt, Boc, Pbf, OtBu and Trt;
3) reacting TFA/DCM solution with conotoxin straight chain peptide resin, filtering to obtain conotoxin straight chain peptide with side chain protecting group, and cyclizing a first pair of disulfide bonds by mercaptoethanol/DMF to obtain a precursor peptide of conotoxin anti-wrinkle peptide with side chain protecting group containing a pair of disulfide bonds;
4) after the first cyclization is completed, removing all side chain protecting groups on the conus anti-wrinkle element precursor peptide with side chain protecting groups containing a pair of disulfide bonds by using a lysis solution to obtain the conus anti-wrinkle element precursor peptide containing a pair of disulfide bonds, adjusting the pH of the solution to 8-9 by using dilute ammonia water after dissolution, and performing cyclization of a second pair of disulfide bonds and a third pair of disulfide bonds under natural conditions to obtain a crude conus anti-wrinkle element peptide;
5) and (4) performing semi-preparative chromatographic separation and freeze-drying to obtain the conus anti-wrinkle agent.
2. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: the coupling system is formed by combining DIC with any one of HOBT, HOAT and Cl-HOBT, or by combining DIEA with any one of HBTU, HATU, PyBOP or PyAOP, or by combining DIEA with any one of HOBT, HOAT and Cl-HOBT.
3. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: in the step 1), the substitution degree of the Sieber Amide Resin is 0.34-0.45 mmol/g.
4. A process for preparing a conotoxin as claimed in claim 2, wherein the process comprises the steps of: in the selection of side chain protecting groups of Cys, the 10 th and 22 th Cys side chain protecting groups can be selected as StBu, and the rest Cys side chain protecting groups are Trt; or the protecting groups of the Cys side chains at the 4 th position and the 21 st position are StBu, and the protecting groups of the other Cys side chains are Trt; or the Cys side chain protecting groups at the 3 rd and 15 th positions are StBu, and the rest Cys side chain protecting groups are Trt.
5. A process for preparing a conotoxin as claimed in claim 3, wherein the process comprises the following steps: in step 2), when Fmoc-Gly-Pro-OH was used as the reaction material at the 6 th and 7 th positions and Fmoc-Ser (tBu) -OH was used as the reaction material at the 11 th and 12 th positions, the reaction material was 2 times the molar number of the Sieber Amide Resin.
6. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: in step 3), the ratio of TFA to DCM in the TFA/DCM solution is 2% -8% by volume.
7. A process for preparing a conotoxin as claimed in claim 6, wherein the process comprises the steps of: in step 3), the ratio of TFA to DCM in TFA/DCM solution was 3% by volume.
8. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: in the step 3), the volume ratio of mercaptoethanol to DMF in the mercaptoethanol/DMF solution is 15-35%, and the oxidant and solvent used for the cyclization of the first pair of disulfide bonds is H2O2DCM, in which H2O2The volume ratio of the active component to DCM is 0.5% -1.5%.
9. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: in the step 4), the volume ratio of each component of the lysate for cracking the precursor peptide of the conus anti-wrinkle peptide with the side chain protecting group containing a pair of disulfide bonds is TFA: ethanedithiol: phenol: triisopropylsilane: water ═ 85-90): (5-8): (3-4): (2-3): (1-3).
10. The preparation process of conotoxin according to claim 1, wherein the preparation process comprises the following steps: in the step 4), the air oxidation method is used for cyclizing the second and third pairs of disulfide bonds, and the reaction time is 48-72 h.
CN202011079899.2A 2020-10-10 2020-10-10 Preparation process of conus anti-wrinkle agent Pending CN112279905A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011079899.2A CN112279905A (en) 2020-10-10 2020-10-10 Preparation process of conus anti-wrinkle agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011079899.2A CN112279905A (en) 2020-10-10 2020-10-10 Preparation process of conus anti-wrinkle agent

Publications (1)

Publication Number Publication Date
CN112279905A true CN112279905A (en) 2021-01-29

Family

ID=74422435

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011079899.2A Pending CN112279905A (en) 2020-10-10 2020-10-10 Preparation process of conus anti-wrinkle agent

Country Status (1)

Country Link
CN (1) CN112279905A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104974237A (en) * 2015-07-18 2015-10-14 济南康和医药科技有限公司 Solid-phase synthesis method of ziconotide by segment process
US20170157016A1 (en) * 2012-04-13 2017-06-08 Activen Cosmetic composition comprising a muconopeptide
CN108047324A (en) * 2018-02-01 2018-05-18 润辉生物技术(威海)有限公司 A kind of preparation method of omega-conotoxin GVIA
CN108440652A (en) * 2018-04-02 2018-08-24 杭州固拓生物科技有限公司 A kind of solid phase synthesis process of Pu Kana peptides
CN110698553A (en) * 2019-08-14 2020-01-17 应连心 Preparation method of conus anti-wrinkle agent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170157016A1 (en) * 2012-04-13 2017-06-08 Activen Cosmetic composition comprising a muconopeptide
CN104974237A (en) * 2015-07-18 2015-10-14 济南康和医药科技有限公司 Solid-phase synthesis method of ziconotide by segment process
CN108047324A (en) * 2018-02-01 2018-05-18 润辉生物技术(威海)有限公司 A kind of preparation method of omega-conotoxin GVIA
CN108440652A (en) * 2018-04-02 2018-08-24 杭州固拓生物科技有限公司 A kind of solid phase synthesis process of Pu Kana peptides
CN110698553A (en) * 2019-08-14 2020-01-17 应连心 Preparation method of conus anti-wrinkle agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BONDEBJERG J 等: "Solid-phase synthesis and biological activity of a thioether analogue of conotoxin G1", 《CHEMBIOCHEM》 *
安婷婷等: "天然芋螺毒素肽的化学合成", 《中国海洋药物》 *

Similar Documents

Publication Publication Date Title
EP3392266B1 (en) Linaclotide synthesis method
CN113801197B (en) Preparation method of procalcitonin
CN110698553B (en) Preparation method of cono anti-wrinkle agent
WO2012174817A1 (en) Method for preparing nesiritide
CN110818790A (en) Preparation method of temeprelin
CN110903352A (en) Preparation method of cetrorelix
KR20210102362A (en) Improved process for making plecanatide
CN112062829B (en) Preparation method of elcatonin
CN107778351B (en) Method for synthesizing octreotide by all-solid-phase method
CN104311639B (en) A kind of synthesis technique of growth hormone release inhibiting hormone
CN112194708A (en) Preparation method of procatide
CN112279905A (en) Preparation process of conus anti-wrinkle agent
CN111057129B (en) Preparation method and kit for synthesizing polypeptide containing two pairs of disulfide bonds, and preparation method of pramipexole
CN112321699B (en) Synthesis method of semaglutide
CN115057912A (en) Method for preparing procatide
CN105367627A (en) Method for preparing terlipressin
CN112062813B (en) Synthesis method of desmopressin
CN113861274A (en) Preparation method of linaclotide
CN110981939A (en) Preparation method of polycaprolactam
CN111732632A (en) Synthesis method of linaclotide
CN115651075B (en) Synthesis method of Tirzepatide
CN112521482B (en) Preparation method for synthesizing nesiritide by solid-liquid combination
CN112812172B (en) Preparation process of lixisenatide
CN113880921B (en) Synthetic method of bremer langdan acetate
CN111499719B (en) Method for synthesizing pramlintide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210129

RJ01 Rejection of invention patent application after publication